1
项与 Seasonal Trivalent Inactivated Split Virion Influenza Vaccine(The Government Pharmaceutical Organization) 相关的临床试验A Phase I/II Randomized Double Blind Controlled Study to Evaluate the Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Split Virion Influenza Vaccine in Healthy Thai Adults Aged Between 18 Years to 49 Years
The study is aim to evaluate the safety and immunogenicity of one dose (15 μg HA per strain per dose) of the GPO seasonal trivalent inactivated split virion influenza vaccine (Tri Fluvac) in healthy adults aged 18 to 49 years over 90 days post-injection.
100 项与 Seasonal Trivalent Inactivated Split Virion Influenza Vaccine(The Government Pharmaceutical Organization) 相关的临床结果
100 项与 Seasonal Trivalent Inactivated Split Virion Influenza Vaccine(The Government Pharmaceutical Organization) 相关的转化医学
100 项与 Seasonal Trivalent Inactivated Split Virion Influenza Vaccine(The Government Pharmaceutical Organization) 相关的专利(医药)
100 项与 Seasonal Trivalent Inactivated Split Virion Influenza Vaccine(The Government Pharmaceutical Organization) 相关的药物交易